Global Standard IV Administration Sets Market Size By Type (Vented, Non Vented), By Application (Chemical Plant, Pharmaceutical Companies), By Region, And Segment Forecasts, 2023 to 2032

The Global Standard IV Administration Sets Market was valued at USD 5.9 billion in 2023 and is projected to reach USD 9.1 billion by 2031, expanding at a CAGR of 5.8% during the forecast period (2023–2031). The market growth is fueled by the rising incidence of chronic illnesses, the growing geriatric population, and the increasing number of hospital admissions requiring intravenous therapies. Standard IV administration sets are essential in delivering fluids, medications, and nutrients directly into a patient’s bloodstream with precision and safety, making them indispensable in both acute and chronic care settings.

Drivers:

1. Increasing Prevalence of Chronic Diseases:

Rising global cases of diabetes, cancer, cardiovascular, and renal diseases are contributing to the higher use of IV therapy, thus boosting demand for IV administration sets.

2. Growth in Hospital Admissions & Surgical Procedures:

An upsurge in hospitalizations and elective surgeries requiring perioperative IV access has escalated the need for dependable and sterile IV sets.

3. Technological Advancements in IV Equipment:

Improvements such as air-eliminating filters, safety-engineered devices, and closed system IV sets are increasing product reliability and reducing infection risks, supporting broader adoption.

Restraints:

1. Risk of Catheter-Related Bloodstream Infections (CRBSIs):

Despite improved technologies, IV administration remains associated with infection risks, potentially hindering adoption in low-resource settings.

2. Regulatory and Compliance Challenges:

Strict regulatory requirements for medical devices, particularly in the U.S. and EU, can delay product approvals and increase compliance costs.

Opportunity:

1. Rising Demand in Home Healthcare Settings:

As healthcare shifts toward patient-centric and cost-effective home care, the demand for easy-to-use IV administration sets is expected to grow.

2. Expanding Healthcare Infrastructure in Emerging Markets:

Healthcare investments in Asia-Pacific, Latin America, and the Middle East are driving greater access to intravenous therapies, offering lucrative growth prospects.

Market by System Type Insights:

The Gravity IV Sets segment dominated the market in 2023 due to their simplicity, cost-effectiveness, and widespread use in hospitals and emergency care. However, the Volumetric Infusion Sets segment is expected to witness the fastest growth, driven by their precision dosing capability—crucial for pediatric and critical care settings.

Market by End-use Insights:

In terms of end-use, Hospitals emerged as the largest segment in 2023, accounting for over 60% of the global market share. The increasing number of inpatient procedures and high prevalence of chronic disease care contribute to this trend. Meanwhile, the Homecare segment is projected to grow at a significant rate due to the increasing preference for at-home treatment for chronic conditions.

Market by Regional Insights:

North America held the dominant position in 2023, supported by a well-established healthcare infrastructure and high adoption of advanced IV therapies. Asia-Pacific, on the other hand, is forecasted to register the highest growth rate during 2023–2031, driven by rapid improvements in healthcare access, rising patient awareness, and government initiatives to improve care delivery systems.

Competitive Scenario:

Major players in the global market include Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi, Terumo Corporation, Nipro Corporation, Smiths Medical, Poly Medicure Ltd., CODAN Companies, and Vogt Medical Vertrieb GmbH. Key strategic moves include product innovation, regional expansions, and partnerships with healthcare facilities to enhance distribution networks.

Scope of Work – Global Standard IV Administration Sets Market

Report Metric Details

Market Size (2023) USD 5.9 billion

Projected Market Size (2031) USD 9.1 billion

CAGR (2023–2031) 5.8%

Market Segments System Type (Gravity Sets, Volumetric Sets), End-use, Region

Growth Drivers Rise in chronic diseases, increase in surgical procedures, expansion of home care

Opportunities Home healthcare growth, healthcare development in emerging markets

Key Market Developments:

2023: Baxter launched a next-generation IV administration set with enhanced needleless connectors and air elimination filters to improve infusion safety.

2024: ICU Medical expanded its manufacturing facility in India to meet increasing demand in Asia-Pacific.

2025: Fresenius Kabi introduced an eco-friendly IV set series with recyclable packaging and reduced plastic components to align with global